Beijing Foyou Pharma CO.(SH:601089) Xin Lang Cai Jing·2025-11-27 06:25Group 1 - The core viewpoint of the news is that Fuyuan Pharmaceutical's stock has increased by 5.01%, reaching a price of 25.76 yuan per share, with a trading volume of 432 million yuan and a turnover rate of 3.65%, resulting in a total market capitalization of 12.365 billion yuan [1] - Fuyuan Pharmaceutical, established on February 3, 1999, is located in Tongzhou District, Beijing, and was listed on June 30, 2022. The company's main business involves the research, production, and sales of pharmaceutical preparations and medical devices, with pharmaceutical preparations accounting for 94.09% of revenue and medical devices 6.00% [1] Group 2 - Among the top ten circulating shareholders of Fuyuan Pharmaceutical, a fund under E Fund ranks as a significant shareholder. The E Fund Healthcare Industry Mixed A (110023) entered the top ten circulating shareholders in the third quarter, holding 2.5638 million shares, which represents 0.53% of the circulating shares. The estimated floating profit today is approximately 3.1535 million yuan [2] - The E Fund Healthcare Industry Mixed A (110023) was established on January 28, 2011, with a latest scale of 3.802 billion yuan. Year-to-date returns are 39.49%, ranking 1421 out of 8130 in its category; the one-year return is 35.06%, ranking 1969 out of 8054; and since inception, the return is 324.9% [2] - The fund manager of E Fund Healthcare Industry Mixed A is Yang Zhenshao, who has been in the position for 9 years and 102 days. The total asset scale under management is 9.816 billion yuan, with the best fund return during the tenure being 215.53% and the worst being -12.11% [2]